Search research articles
Contact Us
Filters
Showing results (401-410 of 437) with videos related to
Page
of 44
Sort By:
ESMO Open
|
January 10, 2021
Single-arm, open label prospective trial to assess prediction of the role of ERCC1/XPF complex in the response of advanced NSCLC patients to platinum-based chemotherapy
M Ganzinelli, H Linardou, M F Alvisi, et al.
ESMO Open
|
January 1, 2022
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up
A Lasagna, D Lilleri, F Agustoni, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
May 6, 2014
European Confederation of Medical Mycology (ECMM) epidemiological survey on invasive infections due to Fusarium species in Europe
A M Tortorano, A Prigitano, M C Esposto, et al.
Plos One
|
March 12, 2014
Multicenter phase II study of sequential radioembolization-sorafenib therapy for inoperable hepatocellular carcinoma
Pierce K H Chow, Donald Y H Poon, Maung-Win Khin, et al.
Communications Biology
|
November 3, 2021
CD36 maintains the gastric mucosa and associates with gastric disease
Miriam Jacome-Sosa, Zhi-Feng Miao, Vivek S Peche, et al.
Folia Biologica
|
September 16, 2003
Allogeneic gene-modified tumour cells in metastatic kidney cancer. Preliminary report
G Pizza, C De Vinci, G Lo Conte, et al.
Advances in Radiation Oncology
|
July 17, 2023
Development and Dosimetric Characterization of a Customizable Shield for Subtotal Skin Electron Beam Therapy
J John Lucido, Gregory P Penoncello, Brady S Laughlin, et al.
ESMO Open
|
September 20, 2021
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study
A Lasagna, F Agustoni, E Percivalle, et al.
Journal of Cardiovascular Computed Tomography
|
February 24, 2019
Prognostic value of CT myocardial perfusion imaging and CT-derived fractional flow reserve for major adverse cardiac events in patients with coronary artery disease
M van Assen, C N De Cecco, M Eid, et al.
Gut
|
February 15, 2018
Immune activation underlies a sustained clinical response to Yttrium-90 radioembolisation in hepatocellular carcinoma
Valerie Chew, Yun Hua Lee, Lu Pan, et al.
Page
of 44
Search research articles
Search
Showing results (401-410 of 437) with videos related to
Sort By:
Page
of 44
ESMO Open
|
January 10, 2021
Single-arm, open label prospective trial to assess prediction of the role of ERCC1/XPF complex in the response of advanced NSCLC patients to platinum-based chemotherapy
M Ganzinelli, H Linardou, M F Alvisi, et al.
ESMO Open
|
January 1, 2022
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up
A Lasagna, D Lilleri, F Agustoni, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
May 6, 2014
European Confederation of Medical Mycology (ECMM) epidemiological survey on invasive infections due to Fusarium species in Europe
A M Tortorano, A Prigitano, M C Esposto, et al.
Plos One
|
March 12, 2014
Multicenter phase II study of sequential radioembolization-sorafenib therapy for inoperable hepatocellular carcinoma
Pierce K H Chow, Donald Y H Poon, Maung-Win Khin, et al.
Communications Biology
|
November 3, 2021
CD36 maintains the gastric mucosa and associates with gastric disease
Miriam Jacome-Sosa, Zhi-Feng Miao, Vivek S Peche, et al.
Folia Biologica
|
September 16, 2003
Allogeneic gene-modified tumour cells in metastatic kidney cancer. Preliminary report
G Pizza, C De Vinci, G Lo Conte, et al.
Advances in Radiation Oncology
|
July 17, 2023
Development and Dosimetric Characterization of a Customizable Shield for Subtotal Skin Electron Beam Therapy
J John Lucido, Gregory P Penoncello, Brady S Laughlin, et al.
ESMO Open
|
September 20, 2021
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study
A Lasagna, F Agustoni, E Percivalle, et al.
Journal of Cardiovascular Computed Tomography
|
February 24, 2019
Prognostic value of CT myocardial perfusion imaging and CT-derived fractional flow reserve for major adverse cardiac events in patients with coronary artery disease
M van Assen, C N De Cecco, M Eid, et al.
Gut
|
February 15, 2018
Immune activation underlies a sustained clinical response to Yttrium-90 radioembolisation in hepatocellular carcinoma
Valerie Chew, Yun Hua Lee, Lu Pan, et al.
Page
of 44